Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol
Authors:
Open Access
- 31 March 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (22) , 36368-36382
Abstract
Involvement of miR-106b in tumorigenic actions of both prolactin and estradiolKeywords
This publication has 81 references indexed in Scilit:
- Upregulation of miR‐153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancerThe Prostate, 2012
- MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancerOncogene, 2012
- The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancerOncogene, 2012
- p21 CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivoProceedings of the National Academy of Sciences, 2009
- Biological determinants of endocrine resistance in breast cancerNature Reviews Cancer, 2009
- Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferaseCarcinogenesis, 2009
- p21 and p27: roles in carcinogenesis and drug resistanceExpert Reviews in Molecular Medicine, 2008
- MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle ProgressionMolecular and Cellular Biology, 2008
- Tamoxifen-stimulated growth of breast cancer due to p21 lossProceedings of the National Academy of Sciences, 2008
- Pathways to tamoxifen resistanceCancer Letters, 2007